Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T22:54:06.924Z Has data issue: false hasContentIssue false

Valproic Acid and Congenital Malformations

Published online by Cambridge University Press:  18 September 2015

D. Lindhout*
Affiliation:
Department of Clinical Genetics, Erasmus Universiteit Rotterdam, Rotterdam
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Canadian Neurological Sciences Federation 1988

References

REFERENCES

1.Huot, C, Gauthier, M, Lebel, M, et al. Congenital malformations associated with maternal use of Valproic acid. Can J Neurol Sci 1987; 14: 290293.CrossRefGoogle ScholarPubMed
2.Lindhout, D, Schmidt, D. ln-utero exposure to valproate and neural tube defects. Lancet 1986; 1: 13921393.CrossRefGoogle ScholarPubMed
3.Robert, E, Rosa, F. Valproateand birth defects. Lancet 1983; 2: 1142.CrossRefGoogle ScholarPubMed
4.Nau, H, Rating, D, Koch, S, et al. Valproic acid and its metabolites; placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981; 219: 768777.Google ScholarPubMed
5.Jäger-Roman, , Deichl, A, Jakob, S, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108: 9971004.CrossRefGoogle ScholarPubMed
6.Wolf, H and Leschot, NJ. Prenataal onderzoek naar defecten van de neurale buis bij gebruik van valproinezuur. Ned Tijdschr Geneesk 1985; 129: 18911892 (summary in English).Google Scholar